Funder: Alzheimer's Drug Discovery Foundation

Due Dates: September 15, 2025 (Letter of Intent) | November 17, 2025 (Invited Full Proposal)

Funding Amounts: Up to $5,000,000 per award; multi-year funding based on stage and scope of research.

Summary: Supports IND-enabling studies and early-stage clinical trials for Alzheimer's therapeutics and biomarker development worldwide.

Key Information: Focus on novel drug mechanisms related to aging biology; anti-amyloid and cholinesterase inhibitor proposals not considered.